First-in-human trial of investigational gene therapy AB-1002 designed to evaluate safety and preliminary efficacy in ...

The immediate past Chief Medical Director of LAUTECH Teaching Hospital, Ogbomoso, Oyo State, Prof. O. G. Opadijo, is a consultant cardiologist and expert in cardiology medicine. In this interview by ...

Italy: A new 15-year analysis has revealed that patients with chronic obstructive pulmonary disease (COPD) who also have ...

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) on Monday released topline data from RSVHR Phase 2b study of zelicapavir in outpatient adults with acute respiratory syncytial virus (RSV) infection who are ...

Brook.ai is making remote care an integral part of U.S. healthcare, extending continuity of care outside the traditional practice setting and delivering measurable improvements in patient outcomes.

This 5-star plan is more than a product – it’s a promise to Nevada seniors that high-quality care can be both accessible and affordable,” said Dawn Maroney, CEO of Alignment Health Plan and president ...

YUFLYMA® (adalimumab-aaty), and its unbranded version, are now approved for two additional pediatric indications - adolescent hidradenitis suppurativa (HS) and pediatric uveitis (UV), in the ...

A team of physicists has developed a groundbreaking method for detecting congestive heart failure with greater ease and precision than previously thought possible. This multidisciplinary study, ...

Systolic congestive heart failure involves the left side of your heart losing its ability to pump effectively. Common ...

Heart attack and heart failure are two distinct but often confused cardiovascular conditions. A heart attack occurs suddenly when blood flow to part of the heart muscle is blocked, causing tissue ...